Skip to main content

Fennec Pharmaceuticals Inc.

FENC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001211583

In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 5 sales; 118 institutions reported holding it in 13F filings for Q3 2026, worth $191.4M in total; no superinvestor holds it.

13F holders, Q3 2026

Institutional positions in Fennec Pharmaceuticals Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
118
+15 vs. Q2 2026
Shares held
18.0M
+1.66M (+10.2%) vs. Q2 2026
Total value
$191.4M
+$16.4M (+9.4%) vs. Q2 2026
New holders
22
37 more added
Sold out
7
31 more reduced

2 institutions that held it in Q2 2026 haven't filed for Q3 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting FENC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2026: 118 institutions
Q1 2021: 53 institutionsQ2 2021: 39 institutionsQ3 2021: 32 institutionsQ4 2021: 30 institutionsQ1 2022: 28 institutionsQ2 2022: 28 institutionsQ3 2022: 31 institutionsQ4 2022: 43 institutionsQ1 2023: 54 institutionsQ2 2023: 56 institutionsQ3 2023: 55 institutionsQ4 2023: 56 institutionsQ1 2024: 65 institutionsQ2 2024: 64 institutionsQ3 2024: 63 institutionsQ4 2024: 64 institutionsQ1 2025: 68 institutionsQ2 2025: 78 institutionsQ3 2025: 84 institutionsQ4 2025: 96 institutionsQ1 2026: 91 institutionsQ2 2026: 105 institutionsQ3 2026: 118 institutions
Value heldQ3 2026: $191.4M
Q1 2021: $89.3MQ2 2021: $88.0MQ3 2021: $109.7MQ4 2021: $49.9MQ1 2022: $64.1MQ2 2022: $63.2MQ3 2022: $92.1MQ4 2022: $119.5MQ1 2023: $108.5MQ2 2023: $124.5MQ3 2023: $107.6MQ4 2023: $168.4MQ1 2024: $161.1MQ2 2024: $87.7MQ3 2024: $74.6MQ4 2024: $101.4MQ1 2025: $81.6MQ2 2025: $112.9MQ3 2025: $129.8MQ4 2025: $119.6MQ1 2026: $99.6MQ2 2026: $175.1MQ3 2026: $191.4M
Institutions holding FENC and their total value by quarter
QuarterHoldersValue
Q3 2026118$191.4M
Q2 2026105$175.1M
Q1 202691$99.6M
Q4 202596$119.6M
Q3 202584$129.8M
Q2 202578$112.9M
Q1 202568$81.6M
Q4 202464$101.4M
Q3 202463$74.6M
Q2 202464$87.7M
Q1 202465$161.1M
Q4 202356$168.4M
Q3 202355$107.6M
Q2 202356$124.5M
Q1 202354$108.5M
Q4 202243$119.5M
Q3 202231$92.1M
Q2 202228$63.2M
Q1 202228$64.1M
Q4 202130$49.9M
Q3 202132$109.7M
Q2 202139$88.0M
Q1 202153$89.3M

Institutions, Q3 2026

Shares, value and share of portfolio for each institution holding Fennec Pharmaceuticals Inc.; share changes are against Q2 2026.

Institutions holding FENC in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Two Sigma Investments, LP178,039$1.90M0.00%+117,707+195.1%Added
Nuveen, LLC186,903$1.99M0.00%+55,421+42.2%Added
Los Angeles Capital Management LLC191,688$2.04M0.01%+166,377+657.3%Added
Vanguard Portfolio Management LLC203,055$2.16M0.00%+3,057+1.5%Added
Potomac Capital Management, Inc.224,500$2.39M1.91%+1000.0%Added
Qube Research & Technologies Ltd252,940$2.69M0.00%+194,648+333.9%Added
Morgan Stanley279,628$2.98M0.00%+57,708+26.0%Added
CenterBook Partners LP304,955$3.25M0.15%+186,373+157.2%Added
Essex Investment Management Co LLC318,771$3.39M0.50%+318,771New
Geode Capital Management, LLC409,061$4.36M0.00%+6,495+1.6%Added
State Street Corp425,689$4.53M0.00%−315−0.1%Reduced
Vanguard Capital Management LLC839,306$8.94M0.00%00.0%Unchanged
Prospect Capital Advisors, LLC886,600$9.44M4.66%+388,800+78.1%Added
AWM Investment Company, Inc.1,160,296$12.4M1.19%00.0%Unchanged
Solas Capital Management, LLC1,433,282$15.3M8.52%−456,084−24.1%Reduced
BlackRock, Inc.2,033,398$21.7M0.00%+306,329+17.7%Added
AIGH Capital Management LLC2,499,421$26.6M3.02%+13,383+0.5%Added
Rosalind Advisors, Inc.3,188,001$34.0M10.98%00.0%Unchanged
Cornerstone Capital, Inc.0$00.00%−105,000−100.0%Sold out
Eleva Capital SAS0$00.00%−53,234−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−21,474−100.0%Sold out
Kemnay Advisory Services Inc.0$00.00%−12,586−100.0%Sold out
Nano Cap New Millennium Growth Fund L P0$00.00%−7,500−100.0%Sold out
National Bank of Canada0$00.00%−141−100.0%Sold out
Cornerstone Planning Group LLC0$00.00%−88−100.0%Sold out
Royal Bank of Canada––––Not filed
Core Capital Management & Research, inc.––––Not filed